| Literature DB >> 6801979 |
Abstract
Two hundred and ten healthy young women volunteered to take a combined oral contraceptive (OC) and to have glucose tolerance in insulin secretion measured in a projected 3-year study with roughly annual investigations. Although the dropout rate was high, glucose tolerance was noted to deteriorate progressively and insulin secretion to rise initially, but thereafter they remained constant. Eventually, insulin levels were lower than would have been expected from the prevailing glucose values. This combination of steroids produced marked insulin resistance to which the pancreas could respond by further insulin secretion. It is suggested that levonorgestrel is too strong a progestin for routine use in the combined OC, and it is recommended that its dose be reduced further or that weaker progestins such as norethindrone be used.Entities:
Keywords: Age Factors; Biology; Body Weight; Carbohydrate Metabolic Effects--analysis; Cardiovascular Effects; Cohort Analysis; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Contraceptive Methods--side effects; Ethinyl Estradiol; Ethnic Groups; Examinations And Diagnoses; Family Planning; Glucose Metabolism Effects; Glucose Tolerance Test--analysis; Laboratory Examinations And Diagnoses; Laboratory Procedures; Levonorgestrel--analysis; Metabolic Effects; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Physiology; Research Methodology
Mesh:
Substances:
Year: 1982 PMID: 6801979 DOI: 10.1016/s0002-9378(16)32481-4
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN: 0002-9378 Impact factor: 8.661